Bicara Therapeutics Inc.
BCAX
$14.81
$0.271.86%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 112.51% | -- | -- | 4,802.72% | |
| Total Receivables | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | 2,305.63% | -- | -- | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | |
| Total Current Assets | 117.48% | -- | -- | -- | |
|
|
|||||
| Total Current Assets | 117.48% | -- | -- | -- | |
| Net Property, Plant & Equipment | 3.68% | -- | -- | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 216.05% | -- | -- | -- | |
| Total Assets | 117.96% | -- | -- | -- | |
|
|
|||||
| Total Accounts Payable | 41.49% | -- | -- | -- | |
| Total Accrued Expenses | 10.86% | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 112.98% | -- | -- | -- | |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | |
| Total Other Current Liabilities | -- | -- | -- | -- | |
| Total Current Liabilities | 19.26% | -- | -- | -- | |
|
|
|||||
| Total Current Liabilities | 19.26% | -- | -- | -- | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | -64.78% | -- | -- | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -- | -- | -- | -- | |
| Total Liabilities | 17.11% | -- | -- | -- | |
|
|
|||||
| Common Stock & APIC | 16,666.02% | -- | -- | -- | |
| Retained Earnings | -44.44% | -- | -- | -- | |
| Treasury Stock & Other | -- | -- | -- | -- | |
| Total Common Equity | 430.63% | -- | -- | -76.89% | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | 350.51% | |
|
|
|||||
| Total Common Equity | 430.63% | -- | -- | -76.89% | |
| Total Preferred Equity | -- | -- | -- | 350.51% | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 125.11% | -- | -- | 1,214.14% | |
|
|
|||||